Enlivex Therapeutics Ltd (ENLV)
1.41
+0.01
(+0.71%)
USD |
NASDAQ |
May 17, 16:00
1.41
0.00 (0.00%)
After-Hours: 20:00
Enlivex Therapeutics Total Liabilities (Quarterly): 6.747M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.747M |
| September 30, 2023 | 8.157M |
| June 30, 2023 | 8.693M |
| March 31, 2023 | 9.448M |
| December 31, 2022 | 10.80M |
| September 30, 2022 | 9.14M |
| June 30, 2022 | 8.855M |
| March 31, 2022 | 10.97M |
| December 31, 2021 | 10.11M |
| September 30, 2021 | 10.08M |
| June 30, 2021 | 4.981M |
| March 31, 2021 | 5.357M |
| December 31, 2020 | 4.871M |
| September 30, 2020 | 4.873M |
| June 30, 2020 | 5.245M |
| March 31, 2020 | 5.592M |
| December 31, 2019 | 6.278M |
| September 30, 2019 | 5.434M |
| June 30, 2019 | 5.468M |
| Date | Value |
|---|---|
| March 31, 2019 | 5.59M |
| December 31, 2018 | 1.328M |
| June 30, 2018 | 0.144M |
| December 31, 2017 | 0.46M |
| September 30, 2017 | 0.537M |
| June 30, 2017 | 0.792M |
| March 31, 2017 | 1.618M |
| December 31, 2016 | 1.931M |
| September 30, 2016 | 1.999M |
| June 30, 2016 | 1.468M |
| March 31, 2016 | 2.30M |
| December 31, 2015 | 2.584M |
| September 30, 2015 | 1.813M |
| June 30, 2015 | 1.768M |
| March 31, 2015 | 1.752M |
| December 31, 2014 | 2.28M |
| September 30, 2014 | 1.146M |
| June 30, 2014 | 0.715M |
| December 31, 2013 | 0.131M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.871M
Minimum
Dec 2020
10.97M
Maximum
Mar 2022
7.426M
Average
6.747M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd | 55.78M |
| Pluri Inc | 34.54M |
| BioLine Rx Ltd | 50.70M |
| Can Fite Biofarma Ltd | 3.746M |
| BiomX Inc | 21.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.83M |
| Shareholders Equity (Quarterly) | 30.08M |